Balance Sheet
Cash Flow Statement
AmortizationBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in Net LoansChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Share-based Compensation (2024 - 2025)

Historic Share-based Compensation for Abivax (ABVX) over the last 2 years, with Q3 2025 value amounting to $13.4 million.

  • Abivax's Share-based Compensation rose 18109.08% to $13.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $30.3 million, marking a year-over-year change of. This contributed to the annual value of $21.6 million for FY2024, which is 14426.78% up from last year.
  • Per Abivax's latest filing, its Share-based Compensation stood at $13.4 million for Q3 2025, which was up 18109.08% from $7.2 million recorded in Q2 2025.
  • In the past 5 years, Abivax's Share-based Compensation registered a high of $13.4 million during Q3 2025, and its lowest value of $4.8 million during Q4 2024.